If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,082.00    -380.00 (-25.99%)
Bid:
1,092.00
Ask:
1,098.00
Spread: 6.00 (0.549%)
Market Cap: £370.45m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Update

15 Jul 2014 07:00

RNS Number : 2877M
Craneware plc
15 July 2014
 



 Craneware plc

("Craneware", "the Group" or the "Company")

Trading Update and Notice of Results

 

 

15 July 2014 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2014.

 

The Board is pleased to confirm the increased sales activity reported earlier in the year  has delivered a record sales performance for the Group with the total value of contracts signed in the year increasing to over  $70m (FY13: $38.5m), an increase in excess of 80% on the prior year.

 

In accordance with the Group's revenue recognition policy, which is focussed on long term sustainable growth and mitigates against year on year fluctuations in the total value of contracts signed, the vast majority of the revenue from these sales has not been recognised in the year to 30 June 2014, and will instead benefit future years. Accordingly the Group expects to report revenues in a range of $42.2m to $43m (FY13: $41.5m) and deliver an adjusted EBITDA in a range of $12.8m to $13.2m (FY13: $12.4m).

 

The market for revenue integrity solutions continues to develop with larger and more complex hospital systems becoming an increasing part of both current year sales and the pipeline of sales opportunities. We continue to invest in our sales organisation to ensure we are optimally positioned to take advantage of this growing market opportunity. Management believes as the fiscal and regulatory pressures on US hospitals continue to grow, the strength and relevance of our unique suite of solutions will increase in this market environment, giving us confidence in continued future growth.

 

Keith Neilson, CEO of Craneware plc commented, "We are delighted to announce a record sales year for the Group, with a year on year increase of over 80% in the total value of contracts signed in the year, demonstrating the ongoing strength of our market position. The current sales success gives Craneware certainty over contracted revenue and associated profits upon which to build future growth."

 

The Company will announce its Full Year Results on 16th September 2014.

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Newgate Threadneedle

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

Heather Armstrong

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGMNNDMGDZM
Date   Source Headline
11th Oct 20224:19 pmRNSHolding(s) in Company
10th Oct 202211:10 amRNSHolding(s) in Company
10th Oct 202211:02 amRNSHolding(s) in Company
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results
7th Jul 20226:13 pmRNSHolding(s) in Company
27th Apr 20221:00 pmRNSBoard Appointment
14th Apr 202212:35 pmRNSBlock listing Interim Review
31st Mar 20224:09 pmRNSTotal Voting Rights
25th Mar 20222:16 pmRNSDividend Currency Election
22nd Mar 20221:37 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Payment Date Update
14th Mar 20227:00 amRNSInterim Results
7th Mar 20225:20 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSBlocklisting Application
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Update and Notice of Results
26th Nov 20215:05 pmRNSDividend Currency Election
19th Nov 20212:46 pmRNSGrant of Long Term Incentive Plan Awards
16th Nov 20212:09 pmRNSResult of AGM
16th Nov 20217:00 amRNSAGM Statement and Integration Update
19th Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Oct 20213:37 pmRNSBlock listing Interim Review
22nd Sep 202112:52 pmRNSPurchase of Shares
21st Sep 20215:58 pmRNSDividend Timetable
21st Sep 20217:00 amRNSFinal Results
20th Jul 20214:53 pmRNSHolding(s) in Company
14th Jul 20215:19 pmRNSHolding(s) in Company
13th Jul 20217:00 amRNSCompletion of SDS Holdco, Inc. Acquisition
13th Jul 20217:00 amRNSTrading Update and Notice of Results
18th Jun 202111:42 amRNSHolding(s) in Company
14th Jun 202110:01 amRNSHolding(s) in Company
10th Jun 202111:55 amRNSHolding(s) in Company
10th Jun 202111:53 amRNSDirector/PDMR Share Dealings
8th Jun 20214:40 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20219:05 amRNSSecond Price Monitoring Extn
8th Jun 20219:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSResults of Placing and Total Voting Rights
7th Jun 20215:27 pmRNSProposed Placing
7th Jun 20215:25 pmRNSAcquisition of SDS Holdco, Inc.
15th Apr 20217:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.